128 related articles for article (PubMed ID: 14672267)
1. Cell-cycle gene expression in lovastatin-induced medulloblastoma apoptosis.
Wang W; Macaulay RJ
Can J Neurol Sci; 2003 Nov; 30(4):349-57. PubMed ID: 14672267
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.
Wang W; Macaulay RJ
Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro.
Macaulay RJ; Wang W; Dimitroulakos J; Becker LE; Yeger H
J Neurooncol; 1999 Mar; 42(1):1-11. PubMed ID: 10360474
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A.
Wang W; Macaulay RJ
Int J Cancer; 1999 Jul; 82(3):430-4. PubMed ID: 10399961
[TBL] [Abstract][Full Text] [Related]
5. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
8. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
9. Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer.
Kaneko R; Tsuji N; Asanuma K; Tanabe H; Kobayashi D; Watanabe N
J Biol Chem; 2007 Jul; 282(27):19273-81. PubMed ID: 17472962
[TBL] [Abstract][Full Text] [Related]
10. Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism.
Vitale M; Di Matola T; Rossi G; Laezza C; Fenzi G; Bifulco M
Endocrinology; 1999 Feb; 140(2):698-704. PubMed ID: 9927296
[TBL] [Abstract][Full Text] [Related]
11. In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent.
Maksimova E; Yie TA; Rom WN
Lung; 2008; 186(1):45-54. PubMed ID: 18034278
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
13. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
[TBL] [Abstract][Full Text] [Related]
14. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
[TBL] [Abstract][Full Text] [Related]
15. Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death.
Park C; Lee I; Kang WK
Carcinogenesis; 2001 Oct; 22(10):1727-31. PubMed ID: 11577016
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach.
Dimitroulakos J; Nohynek D; Backway KL; Hedley DW; Yeger H; Freedman MH; Minden MD; Penn LZ
Blood; 1999 Feb; 93(4):1308-18. PubMed ID: 9949174
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibition.
Müller C; Kiehl MG; van de Loo J; Koch OM
Int J Mol Med; 1999 Jan; 3(1):63-8. PubMed ID: 9864387
[TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin.
Maksumova L; Ohnishi K; Muratkhodjaev F; Zhang W; Pan L; Takeshita A; Ohno R
Leukemia; 2000 Aug; 14(8):1444-50. PubMed ID: 10942241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
